Elizabeth Iorns

Co-founder, President & CEO; Board Director

2011 - Current

Science Exchange is the world's leading marketplace for outsourced research and development, providing efficient access to a network of over 2,500 qualified and pre-contracted contract research organizations (CROs) and manufacturers (CMOs), academic labs, and government facilities. Supported by top venture capital firms including Maverick Capital, Union Square Ventures, Norwest Venture Partners and Y Combinator, Science Exchange has raised more than $60M in venture capital funding.

Scientific Founder & Advisor

2020

Transcripta Bio (formerly Rarebase) https://www.transcriptabio.com/

Part-time partner

2014 - 2020

Helped to establish the "YC bio" program for early stage life science companies.

Angel Investor

2014 - 2020

Angel investor in science, health and education companies including Asher Biotherapeutics, Avro Therapeutics, Hepatx, Enzyme, Curebase, Notable Labs, NURX, BIOS Health, Torch, Quero Education, Unima, Validere, Vetcove.

Board Director

2017 - 2018

Assistant Professor

2010 - 2011

Postdoctoral Associate

2008 - 2010

Scientific Officer, Breakthrough Breast Cancer Research Center

2003 - 2004